1. Field of the Invention
The present invention generally relates to boehmite particulate material and processes for forming same. More specifically, the present invention relates to seeded boehmite particulate material having morphological features.
2. Description of the Related Art
Boehmite particulate material finds particular application as a desirable raw material for forming aluminous products, for example, alumina abrasive grains having high performance characteristics. In this context, the U.S. Pat. No. 4,797,139, commonly owned by the present Assignee, discloses a particular process for forming boehmite particulate material, which is then used as a feedstock material for later stage processing to form alumina abrasive grains. As described, the boehmite material is formed by a seeded process, and is limited in scope to boehmite particulate material that is adapted to form alumina abrasive grains. As such, the disclosed particulate material has particularly desired spherical morphology, which makes it suitable for abrasive applications.
Beyond abrasive applications, there is a particular desirability for creating boehmite particulate material having varying morphology. Since particulate morphology can have a profound impact upon the applications of the material, a need has arisen in the art for creation of new materials for applications beyond abrasives, including fillers utilized in specialty coating products and various polymer products. Other applications include those in which the boehmite material is utilized in its as-formed state, rather than as a feedstock material. In addition to the interest in creating new materials, processing technology enabling the formation of such materials needs to be developed as well. In this regard, such processing technology is desirably cost effective, is relatively straightforward to control, and provides high yields.
According to one aspect, boehmite particulate material formed by seeded processing has an aspect ratio of not less than 3:1.
According to another aspect of the present invention, a boehmite particulate material is formed by a process that includes providing a boehmite precursor and boehmite seeds in a suspension, and heat treating the suspension to convert the boehmite precursor into boehmite particulate material. The particulate material may have a certain morphology, such as a relatively high aspect ratio, such as not less than about 2:1, such as not less than about 3:1.
Still further, according to another aspect of the present invention, boehmite particulate material is formed by a process including providing a boehmite precursor and boehmite seeds in a suspension, and heat-treating the suspension to convert the boehmite precursor into boehmite particulate material. Here, the boehmite particulate material is comprised of platelets, and has an aspect of not less than about 2:1.
According to an embodiment of the present invention, a boehmite particulate material is formed by a process that includes providing a boehmite precursor and boehmite seeds in a suspension, and heat treating (such as by hydrothermal treatment) the suspension (alternatively sol or slurry) to convert the boehmite precursor into boehmite particulate material formed of particles or crystallites. According to a particular aspect, the boehmite particulate material has a relatively elongated morphology, described generally herein in terms of aspect ratio, described below.
The term “boehmite” is generally used herein to denote alumina hydrates including mineral boehmite, typically being Al2O3.H2O and having a water content on the order of 15%, as well as psuedoboehmite, having a water content higher than 15%, such as 20-38% by weight. It is noted that boehmite (including psuedoboehmite) has a particular and identifiable crystal structure, and accordingly unique X-ray diffraction pattern, and as such, is distinguished from other aluminous materials including other hydrated aluminas such as ATH (aluminum trihydroxide) a common precursor material used herein for the fabrication of boehmite particulate materials.
The aspect ratio, defined as the ratio of the longest dimension to the next longest dimension perpendicular to the longest dimension, is generally not less than 2:1, and preferably not less than 3:1, 4:1, or 6:1. Indeed, certain embodiments have relatively elongated particles, such as not less than 9:1, 10:1, and in some cases, not less than 14:1. With particular reference to needle-shaped particles, the particles may be further characterized with reference to a secondary aspect ratio defined as the ratio of the second longest dimension to the third longest dimension. The secondary aspect ratio is generally not greater than 3:1, typically not greater than 2:1, or even 1.5:1, and oftentimes about 1:1. The secondary aspect ratio generally describes the cross-sectional geometry of the particles in a plane perpendicular to the longest dimension.
Platey or platelet-shaped particles generally have an elongated structure having the aspect ratios described above in connection with the needle-shaped particles. However, platelet-shaped particles generally have opposite major surfaces, the opposite major surfaces being generally planar and generally parallel to each other. In addition, the platelet-shaped particles may be characterized as having a secondary aspect ratio greater than that of needle-shaped particles, generally not less than about 3:1, such as not less than about 6:1, or even not less than 10:1. Typically, the shortest dimension or edge dimension, perpendicular to the opposite major surfaces or faces, is generally less than 50 nanometers.
Morphology of the boehmite particulate material may be further defined in terms of particle size, more particularly, average particle size. Here, the seeded boehmite particulate material, that is, boehmite formed through a seeding process (described in more detail below) has a relatively fine particle or crystallite size. Generally, the average particle size is not greater than about 1000 nanometers, and fall within a range of about 100 to 1000 nanometers. Other embodiments have even finer average particle sizes, such as not greater than about 800 nanometers, 600 nanometers, 500 nanometers, 400 nanometers, and even particles having an average particle size smaller than 300 nanometers, representing a fine particulate material.
As used herein, the “average particle size” is used to denote the average longest or length dimension of the particles. Due to the elongated morphology of the particles, conventional characterization technology is generally inadequate to measure average particle size, since characterization technology is generally based upon an assumption that the particles are spherical or near-spherical. Accordingly, average particle size was determined by taking multiple representative samples and physically measuring the particle sizes found in representative samples. Such samples may be taken by various characterization techniques, such as by scanning electron microscopy (SEM).
The present seeded boehmite particulate material has been found to have a fine average particle size, while oftentimes competing non-seeded based technologies are generally incapable of providing such fine average particle sizes. In this regard, it is noted that oftentimes in the literature, reported particle sizes are not set forth in the context of averages as in the present specification, but rather, in the context of nominal range of particle sizes derived from physical inspection of samples of the particulate material. Accordingly, the average particle size will lie within the reported range in the prior art, generally at about the arithmetic midpoint of the reported range, for the expected Gaussian particle size distribution. Stated alternatively, while non-seeded based technologies may report fine particle size, such fine sizing generally denotes the lower limit of an observed particle size distribution and not average particle size.
Likewise, in a similar manner, the above-reported aspect ratios generally correspond to the average aspect ratio taken from representative sampling, rather than upper or lower limits associated with the aspect ratios of the particulate material. Oftentimes in the literature, reported particle aspect ratios are not set forth in the context of averages as in the present specification, but rather, in the context of nominal range of aspect ratios derived from physical inspection of samples of the particulate material. Accordingly, the average aspect ratio will lie within the reported range in the prior art, generally at about the arithmetic midpoint of the reported range, for the expected Gaussian particle morphology distribution. Stated alternatively, while non-seeded based technologies may report aspect ratio, such data generally denotes the lower limit of an observed aspect ratio distribution and not average aspect ratio.
In addition to aspect ratio and average particle size of the particulate material, morphology of the particulate material may be further characterized in terms of specific surface area. Here, the commonly available BET technique was utilized to measure specific surface area of the particulate material. According to embodiments herein, the boehmite particulate material has a relatively high specific surface area, generally not less than about 10 m2/g, such as not less than about 50 m2/g, 70 m2/g, or not less than about 90 m2/g. Since specific surface area is a function of particle morphology as well as particle size, generally the specific surface area of embodiments was less than about 400 m2/g, such as less than about 350 or 300 m2/g.
Turning to the details of the processes by which the boehmite particulate material may be manufactured, generally ellipsoid, needle, or platelet-shaped boehmite particles are formed from a boehmite precursor, typically an aluminous material including bauxitic minerals, by hydrothermal treatment as generally described in the commonly owned patent described above, U.S. Pat. No. 4,797,139. More specifically, the boehmite particulate material may be formed by combining the boehmite precursor and boehmite seeds in suspension, exposing the suspension (alternatively sol or slurry) to heat treatment to cause conversion of the raw material into boehmite particulate material, further influenced by the boehmite seeds provided in suspension. Heating is generally carried out in an autogenous environment, that is, in an autoclave, such that an elevated pressure is generated during processing. The pH of the suspension is generally selected from a value of less than 7 or greater than 8, and the boehmite seed material has a particle size finer than about 0.5 microns. Generally, the seed particles are present in an amount greater than about 1% by weight of the boehmite precursor (calculated as Al2O3), and heating is carried out at a temperature greater than about 120° C., such as greater than about 125° C., or even greater than about 130° C., and at a pressure greater than about 85 psi, such as greater than about 90 psi, 100 psi, or even greater than about 110 psi.
The particulate material may be fabricated with extended hydrothermal conditions combined with relatively low seeding levels and acidic pH, resulting in preferential growth of boehmite along one axis or two axes. Longer hydrothermal treatment may be used to produce even longer and higher aspect ratio of the boehmite particles and/or larger particles in general.
Following heat treatment, such as by hydrothermal treatment, and boehmite conversion, the liquid content is generally removed, such as through an ultrafiltration process or by heat treatment to evaporate the remaining liquid. Thereafter, the resulting mass is generally crushed, such to 100 mesh. It is noted that the particulate size described herein generally describes the single crystallites formed through processing, rather than the aggregates which may remain in certain embodiments (e.g., for those products that call for and aggregated material).
According to data gathered by the present inventors, several variables may be modified during the processing of the boehmite raw material, to effect the desired morphology. These variables notably include the weight ratio, that is, the ratio of boehmite precursor to boehmite seed, the particular type or species of acid or base used during processing (as well as the relative pH level), and the temperature (which is directly proportional to pressure in an autogenous hydrothermal environment) of the system.
In particular, when the weight ratio is modified while holding the other variables constant, the shape and size of the particles forming the boehmite particulate material are modified. For example, when processing is carried at 180° C. for two hours in a 2 weight % nitric acid solution, a 90:10 ATH:boehmite seed ratio forms needle-shaped particles (ATH being a species of boehmite precursor). In contrast, when the ATH:boehmite seed ratio is reduced to a value of 80:20, the particles become more elliptically shaped. Still further, when the ratio is further reduced to 60:40, the particles become near-spherical. Accordingly, most typically the ratio of boehmite precursor to boehmite seeds is not less than about 60:40, such as not less than about 70:30 or 80:20. However, to ensure adequate seeding levels to promote the fine particulate morphology that is desired, the weight ratio of boehmite precursor to boehmite seeds is generally not greater than about 98:2. Based on the foregoing, an increase in weight ratio generally increases aspect ratio, while a decrease in weight ratio generally decreased aspect ratio.
Further, when the type of acid or base is modified, holding the other variables constant, the shape (e.g., aspect ratio) and size of the particles are affected. For example, when processing is carried out at 100° C. for two hours with an ATH:boehmite seed ratio of 90:10 in a 2 weight % nitric acid solution, the synthesized particles are generally needle-shaped, in contrast, when the acid is substituted with HCl at a content of 1 weight % or less, the synthesized particles are generally near spherical. When 2 weight % or higher of HCl is utilized, the synthesized particles become generally needle-shaped. At 1 weight % formic acid, the synthesized particles are platelet-shaped. Further, with use of a basic solution, such as 1 weight % KOH, the synthesized particles are platelet-shaped. If a mixture of acids and bases is utilized, such as 1 weight % KOH and 0.7 weight % nitric acid, the morphology of the synthesized particles is platelet-shaped.
Suitable acids and bases include mineral acids such as nitric acid, organic acids such as formic acid, halogen acids such as hydrochloric acid, and acidic salts such as aluminum nitrate and magnesium sulfate. Effective bases include, for example, amines including ammonia, alkali hydroxides such as potassium hydroxide, alkaline hydroxides such as calcium hydroxide, and basic salts.
Still further, when temperature is modified while holding other variables constant, typically changes are manifested in particle size. For example, when processing is carried out at an ATH:boehmite seed ratio of 90:10 in a 2 weight % nitric acid solution at 150° C. for two hours, the crystalline size from XRD (x-ray diffraction characterization) was found to be 115 Angstroms. However, at 160° C. the average particle size was found to be 143 Angstroms. Accordingly, as temperature is increased, particle size is also increased, representing a directly proportional relationship between particle size and temperature.
An autoclave was charged with 7.42 lb. of Hydral 710 aluminum trihydroxide purchased from Alcoa; 0.82 lb of boehmite obtained from SASOL under the name—Catapal B pseudoboehmite; 66.5 lb of deionized water; 0.037 lb potassium hydroxide; and 0.18 lb of 22 wt % nitric acid. The boehmite was pre-dispersed in 5 lb of the water and 0.18 lb of the acid before adding to the aluminum trihydroxide and the remaining water and potassium hydroxide.
The autoclave was heated to 185° C. over a 45 minute period and maintained at that temperature for 2 hours with stirring at 530 rpm. An autogenously generated pressure of about 163 psi was reached and maintained. Thereafter the boehmite dispersion was removed from the autoclave. After autoclave the pH of the sol was about 10. The liquid content was removed at a temperature of 65° C. The resultant mass was crushed to less than 100 mesh. The SSA of the resultant powder was about 62 m2/g.
An autoclave was charged with 250 g of Hydral 710 aluminum trihydroxide purchased from Alcoa; 25 g of boehmite obtained from SASOL under the name—Catapal B pseudoboehmite; 1000 g of deionized water; and 34.7 g of 18% nitric acid. The boehmite was pre-dispersed in 100 g of the water and 6.9 g of the acid before adding to the aluminum trihydroxide and the remaining water and acid.
The autoclave was heated to 180° C. over a 45 minute period and maintained at that temperature for 2 hours with stirring at 530 rpm. An autogenously generated pressure of about 150 psi was reached and maintained. Thereafter the boehmite dispersion was removed from the autoclave. After autoclave the pH of the sol was about 3. The liquid content was removed at a temperature of 95° C. The resultant mass was crushed to less than 100 mesh. The SSA of the resultant powder was about 120 m2/g.
An autoclave was charged with 220 g of Hydral 710 aluminum trihydroxide purchased from Alcoa; 55 g of boehmite obtained from SASOL under the name—Catapal B pseudoboehmite; 1000 g of deionized water; and 21.4 g of 18% nitric acid. The boehmite was pre-dispersed in 100 g of the water and 15.3 g of the acid before adding to the aluminum trihydroxide and the remaining water and acid.
The autoclave was heated to 172° C. over a 45 minute period and maintained at that temperature for 3 hours with stirring at 530 rpm. An autogenously generated pressure of about 120 psi was reached and maintained. Thereafter the boehmite dispersion was removed from the autoclave. After autoclave the pH of the sol was about 4. The liquid content was removed at a temperature of 95° C. The resultant mass was crushed to less than 100 mesh. The SSA of the resultant powder was about 135 m2/g.
An autoclave was charged with 165 g of Hydral 710 aluminum trihydroxide purchased from Alcoa; 110 g of boehmite obtained from SASOL under the name—Catapal B pseudoboehmite; 1000 g of deionized water; and 35.2 g of 18% nitric acid. The boehmite was pre-dispersed in 100 g of the water and 30.6 g of the acid before adding to the aluminum trihydroxide and the remaining water and acid.
The autoclave was heated to 160° C. over a 45 minute period and maintained at that temperature for 2.5 hours with stirring at 530 rpm. An autogenously generated pressure of about 100 psi was reached and maintained. Thereafter the boehmite dispersion was removed from the autoclave. After autoclave the pH of the sol was about 3.5. The liquid content was removed at a temperature of 95° C. The resultant mass was crushed to less than 100 mesh. The SSA of the resultant powder was about 196 m2/g.
According to embodiments described herein, a relatively powerful and flexible process methodology may be employed to engineer desired morphologies into the final boehmite product. Of particular significance, embodiments utilize seeded processing resulting in a cost-effective processing route with a high degree of process control which may result in desired fine average particle sizes as well as controlled particle size distributions. The combination of (i) identifying and controlling key variables in the process methodology, such as weight ratio, acid and base species and temperature, and (ii) seeding-based technology is of particular significance, providing repeatable and controllable processing of desired boehmite particulate material morphologies.
Additional characterization studies were carried out to more precisely understand the effect of seeding on particle morphology.
It is recognized that non-seeded approaches have been found to form particulate material, including approaches that decompose raw materials through consumption of an aluminum salt, such as aluminum nitrate or aluminum sulfate. However, these metal salt decomposition approaches form morphologically distinct particulates, that are devoid of the seeded morphology, notably lacking the nodular structure.
Aspects of the present invention enable utilization of the boehmite particulate material in a wide variety of applications, such as a filler in specialty coatings as well as in polymer products. Indeed, the particulate material may be individually and uniformly dispersed within solvents (particularly including polar solvents), and/or polymers without forming aggregates by conventional compounding processes. In addition, the boehmite particulate material may be individually and uniformly dispersed with a non-polar solvents, and/or polymers without forming aggregates by utilizing conventional dispersing agents such as silane coupling agents. Notably, the seeded morphology, having the above-disclosed nodular structure, is understood to have particular properties in the context as a filler in a matrix material, such that the particles have improved adhesion within the matrix due to the seeded nature of the particles. Of course, particular applications of the boehmite particulate material are not so limited and may find commercial use in a variety of applications.
While the invention has been illustrated and described in the context of specific embodiments, it is not intended to be limited to the details shown, since various modifications and substitutions can be made without departing in any way from the scope of the present invention. For example, additional or equivalent substitutes can be provided and additional or equivalent production steps can be employed. As such, further modifications and equivalents of the invention herein disclosed may occur to persons skilled in the art using no more than routine experimentation, and all such modifications and equivalents are believed to be within the scope of the invention as defined by the following claims.
This application is a continuation-in-part application of U.S. patent application Ser. No. 10/845,764, filed May 14, 2004, now abandoned which is (i) a continuation-in-part application of U.S. patent application Ser. No. 10/414,590, filed Apr. 16, 2003, now U.S. Pat. No. 7,189,775, which in turn is a non-provisional application of U.S. Provisional Application 60/374,014 filed Apr. 19, 2002, and (ii) a continuation-in-part application of U.S. patent application Ser. No. 10/823,400, filed Apr. 13, 2004. Priority to the foregoing applications is hereby claimed, and the subject matter thereof hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2763620 | Bugosh | Sep 1956 | A |
2915475 | Bugosh | Dec 1959 | A |
3108888 | Bugosh | Oct 1963 | A |
3321272 | Kerr | May 1967 | A |
3357791 | Napier | Dec 1967 | A |
3385663 | Hughes | May 1968 | A |
3387447 | Trammell et al. | Jun 1968 | A |
3814782 | Hayes et al. | Jun 1974 | A |
3842111 | Meyer-Simon et al. | Oct 1974 | A |
3853688 | D'Ambrosio | Dec 1974 | A |
3865917 | Galasso et al. | Feb 1975 | A |
3873489 | Thurn et al. | Mar 1975 | A |
3950180 | Kato | Apr 1976 | A |
3978103 | Meyer-Simon et al. | Aug 1976 | A |
3997581 | Pletka et al. | Dec 1976 | A |
4002594 | Fetterman | Jan 1977 | A |
4105465 | Berger | Aug 1978 | A |
4117105 | Hertzengerg et al. | Sep 1978 | A |
4120943 | Iwaisako et al. | Oct 1978 | A |
4344928 | Dupin et al. | Aug 1982 | A |
4377418 | Birchall et al. | Mar 1983 | A |
4386185 | Macdonell et al. | May 1983 | A |
4492682 | Trebillion | Jan 1985 | A |
4525494 | Andy | Jun 1985 | A |
4539365 | Rhee | Sep 1985 | A |
4558102 | Miyata | Dec 1985 | A |
4623738 | Sugerman et al. | Nov 1986 | A |
4632364 | Smith | Dec 1986 | A |
4716029 | Oguri et al. | Dec 1987 | A |
4769179 | Kato et al. | Sep 1988 | A |
4797139 | Bauer | Jan 1989 | A |
4891127 | Murrel et al. | Jan 1990 | A |
4946666 | Brown | Aug 1990 | A |
4992199 | Meyer et al. | Feb 1991 | A |
5155085 | Hamano et al. | Oct 1992 | A |
5194243 | Pearson et al. | Mar 1993 | A |
5286290 | Risley | Feb 1994 | A |
5302368 | Harato et al. | Apr 1994 | A |
5306680 | Fukuda | Apr 1994 | A |
5318628 | Matijevic et al. | Jun 1994 | A |
5321055 | Slocum | Jun 1994 | A |
5332777 | Goetz et al. | Jul 1994 | A |
5344489 | Matijevic et al. | Sep 1994 | A |
5401703 | Fukuda | Mar 1995 | A |
5413985 | Thome et al. | May 1995 | A |
5445807 | Pearson | Aug 1995 | A |
5508016 | Yamanishi et al. | Apr 1996 | A |
5527851 | Barron et al. | Jun 1996 | A |
5550180 | Elsik et al. | Aug 1996 | A |
5580914 | Falla et al. | Dec 1996 | A |
5580919 | Agostini et al. | Dec 1996 | A |
5583245 | Parker et al. | Dec 1996 | A |
5663396 | Musleve et al. | Sep 1997 | A |
5684171 | Wideman et al. | Nov 1997 | A |
5684172 | Wideman et al. | Nov 1997 | A |
5696197 | Smith et al. | Dec 1997 | A |
5707716 | Yoshino et al. | Jan 1998 | A |
5723529 | Bernard et al. | Mar 1998 | A |
5849827 | Boediger et al. | Dec 1998 | A |
5900449 | Custodero et al. | May 1999 | A |
5955142 | Yoshino et al. | Sep 1999 | A |
5962124 | Yoshino et al. | Oct 1999 | A |
5989515 | Watanabe et al. | Nov 1999 | A |
6017632 | Pinnavaia et al. | Jan 2000 | A |
6143816 | Prescher et al. | Nov 2000 | A |
6156835 | Anderson et al. | Dec 2000 | A |
6203695 | Harle et al. | Mar 2001 | B1 |
6403007 | Kido et al. | Jun 2002 | B1 |
6413308 | Xu et al. | Jul 2002 | B1 |
6417286 | Agostini et al. | Jul 2002 | B1 |
6440187 | Kasai et al. | Aug 2002 | B1 |
6440552 | Kajihara et al. | Aug 2002 | B1 |
6485656 | Meyer et al. | Nov 2002 | B1 |
6486254 | Barbee et al. | Nov 2002 | B1 |
6534584 | Wideman et al. | Mar 2003 | B2 |
6576324 | Yoshino et al. | Jun 2003 | B2 |
6610261 | Custodero et al. | Aug 2003 | B1 |
6635700 | Cruse et al. | Oct 2003 | B2 |
6646026 | Fan et al. | Nov 2003 | B2 |
6648959 | Fischer et al. | Nov 2003 | B1 |
6653387 | Causa et al. | Nov 2003 | B2 |
6689432 | Kitamura et al. | Feb 2004 | B2 |
6706660 | Park | Mar 2004 | B2 |
6747087 | Custodero et al. | Jun 2004 | B2 |
6841207 | Burch et al. | Jan 2005 | B2 |
6858665 | Larson | Feb 2005 | B2 |
6872444 | McDonald et al. | Mar 2005 | B2 |
6924011 | Van Aert et al. | Aug 2005 | B2 |
7056585 | Mishima et al. | Jun 2006 | B2 |
7189775 | Tang et al. | Mar 2007 | B2 |
7211612 | Kikuchi | May 2007 | B2 |
7226647 | Kasperchik et al. | Jun 2007 | B2 |
7531161 | Tang et al. | May 2009 | B2 |
20020004549 | Custodero et al. | Jan 2002 | A1 |
20020169243 | Nippa | Nov 2002 | A1 |
20030197300 | Tang et al. | Oct 2003 | A1 |
20030202923 | Custodero et al. | Oct 2003 | A1 |
20040030017 | Simonot et al. | Feb 2004 | A1 |
20040120904 | Lye et al. | Jun 2004 | A1 |
20040265219 | Bauer et al. | Dec 2004 | A1 |
20050124745 | Bauer et al. | Jun 2005 | A1 |
20050227000 | Bauer et al. | Oct 2005 | A1 |
20050267238 | Mutin | Dec 2005 | A1 |
20060104895 | Bauer et al. | May 2006 | A1 |
20060106129 | Gernon et al. | May 2006 | A1 |
20060148955 | Guiselin et al. | Jul 2006 | A1 |
20070104952 | Bianchi et al. | May 2007 | A1 |
20080031808 | Bauer et al. | Feb 2008 | A1 |
Number | Date | Country |
---|---|---|
1237146 | Dec 1999 | CN |
1266020 | Sep 2000 | CN |
195426 | May 1982 | CS |
956535 | Jan 1957 | DE |
2163678 | Jul 1973 | DE |
2408122 | Aug 1974 | DE |
2952666 | Jul 1980 | DE |
0 038 620 | Oct 1981 | EP |
0 108 968 | May 1984 | EP |
0 304 721 | Mar 1989 | EP |
0 563 653 | Oct 1993 | EP |
0 667 405 | Aug 1995 | EP |
0 501 227 | Dec 1995 | EP |
0 735 001 | Oct 1996 | EP |
0 885 844 | Dec 1998 | EP |
0 896 021 | Feb 1999 | EP |
1 225 200 | Jul 2002 | EP |
1 256 599 | Nov 2002 | EP |
1 323 775 | Jul 2003 | EP |
0 697 432 | Oct 2003 | EP |
1 000 965 | Oct 2003 | EP |
0 807 603 | Dec 2003 | EP |
1 112 961 | Sep 2004 | EP |
0736392 | Oct 2006 | EP |
1189304 | Apr 1970 | GB |
2248841 | Apr 1992 | GB |
26758 | Sep 1983 | HU |
45-032530 | Oct 1970 | JP |
55-116622 | Sep 1980 | JP |
56-009427 | Jan 1981 | JP |
0 015 196 | Apr 1982 | JP |
58-026029 | Feb 1983 | JP |
58-1865434 | Oct 1983 | JP |
59-193949 | Nov 1984 | JP |
61-179264 | Aug 1986 | JP |
62-030133 | Feb 1987 | JP |
63-147820 | Jun 1988 | JP |
63-147821 | Jun 1988 | JP |
05-279019 | Oct 1993 | JP |
63-22243 | Nov 1994 | JP |
7-18174 | Jan 1995 | JP |
09-208809 | Aug 1997 | JP |
9-511258 | Nov 1997 | JP |
200-239014 | Sep 2000 | JP |
2001-058818 | Mar 2001 | JP |
2001-180930 | Jul 2001 | JP |
2001207077 | Jul 2001 | JP |
2001-261976 | Sep 2001 | JP |
2003-002642 | Jan 2003 | JP |
2003-054941 | Feb 2003 | JP |
2003-107206 | Apr 2003 | JP |
2003-238150 | Aug 2003 | JP |
2004-051390 | Feb 2004 | JP |
2004-59643 | Feb 2004 | JP |
264064 | Jul 1970 | SU |
WO 9511270 | Apr 1995 | WO |
WO 9723566 | Jul 1997 | WO |
WO 9814426 | Apr 1998 | WO |
9935089 | Jul 1999 | WO |
WO 01088265 | Nov 2001 | WO |
WO 03089508 | Oct 2003 | WO |
WO 2004016630 | Feb 2004 | WO |
WO 2004056915 | Jul 2004 | WO |
WO 2004090023 | Oct 2004 | WO |
WO 2005100244 | Oct 2005 | WO |
WO 2005100491 | Oct 2005 | WO |
WO 2006002993 | Jan 2006 | WO |
WO 2006049863 | May 2006 | WO |
WO 2006060206 | Jun 2006 | WO |
WO 2006060468 | Jun 2006 | WO |
WO 2007056404 | May 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20080031808 A1 | Feb 2008 | US |
Number | Date | Country | |
---|---|---|---|
60374014 | Apr 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10845764 | May 2004 | US |
Child | 11834527 | US | |
Parent | 10823400 | Apr 2004 | US |
Child | 10845764 | US | |
Parent | 10414590 | Apr 2003 | US |
Child | 10823400 | US |